Which of the following drugs is a full agonist at opioid receptors, has excellent oral bioavailability, analgesic equipotency to morphine and a longer durationlof action with milder withdrawal symptoms on abrupt discontinuation?
**Core Concept**
The question is testing the student's knowledge of opioid pharmacology, specifically the properties of a full agonist at opioid receptors. A full agonist is a type of drug that binds to a receptor and induces a maximal response, without any ceiling effect.
**Why the Correct Answer is Right**
The correct answer, **Tramadol**, is a full agonist at the μ-opioid receptor, which is responsible for analgesia. It also acts as a serotonin-norepinephrine reuptake inhibitor (SNRI), which contributes to its analgesic effects. Tramadol has excellent oral bioavailability, which allows for convenient oral administration. Its analgesic equipotency to morphine is due to its ability to activate the μ-opioid receptor, while its longer duration of action and milder withdrawal symptoms are attributed to its unique pharmacokinetic profile and partial agonist activity at the δ-opioid receptor.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify a particular drug that matches the description. Without more information, it is impossible to determine which drug is being referred to.
**Option B:** This option is incorrect because it is a partial agonist at the μ-opioid receptor, which would have a ceiling effect on analgesia and may lead to more severe withdrawal symptoms.
**Option C:** This option is incorrect because it is a mixed agonist-antagonist at opioid receptors, which would have limited analgesic effects and may lead to more severe withdrawal symptoms.
**Clinical Pearl / High-Yield Fact**
Tramadol's unique pharmacological profile makes it a useful option for patients with chronic pain who require a longer duration of action and milder withdrawal symptoms. However, it is essential to monitor patients for potential side effects, such as serotonin syndrome, especially when combined with other SNRIs or selective serotonin reuptake inhibitors (SSRIs).
**Correct Answer: C. Tramadol**